Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 278493, 13 pages
http://dx.doi.org/10.1155/2014/278493
Research Article

Potential Retinoid X Receptor Agonists for Treating Alzheimer’s Disease from Traditional Chinese Medicine

1School of Pharmacy, China Medical University, Taichung 40402, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan

Received 4 December 2013; Accepted 4 January 2014; Published 30 April 2014

Academic Editor: Fuu-Jen Tsai

Copyright © 2014 Kuan-Chung Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Crunkhorn, “Neurodegenerative disease: RXR agonist reverses Alzheimer's disease,” Nature Reviews Drug Discovery, vol. 11, no. 4, p. 271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Ghezzi, E. Scarpini, and D. Galimberti, “Disease-modifying drugs in Alzheimer's disease,” Drug Design Development and Therapy, vol. 7, pp. 1471–1479, 2013. View at Google Scholar
  3. F. M. LaFerla, “Preclinical Success against Alzheimer's Disease with an old drug,” New England Journal of Medicine, vol. 367, no. 6, pp. 570–572, 2012. View at Google Scholar
  4. H. Kölsch, D. Lütjohann, F. Jessen et al., “RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism,” Journal of Cellular and Molecular Medicine, vol. 13, no. 3, pp. 589–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Aicardi, “New hope from an old drug: fighting Alzheimer's disease with the cancer drug bexarotene (targretin)?” Rejuvenation Research, vol. 16, no. 6, pp. 524–528, 2013. View at Google Scholar
  6. P. E. Cramer, J. R. Cirrito, D. W. Wesson et al., “ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models,” Science, vol. 335, no. 6075, pp. 1503–1506, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Mark, N. B. Ghyselinck, O. Wendling et al., “A genetic dissection of the retinoid signalling pathway in the mouse,” Proceedings of the Nutrition Society, vol. 58, no. 3, pp. 609–613, 1999. View at Google Scholar · View at Scopus
  8. S. A. Ross, P. J. McCaffery, U. C. Drager, and L. M. De Luca, “Retinoids in embryonal development,” Physiological Reviews, vol. 80, no. 3, pp. 1021–1054, 2000. View at Google Scholar · View at Scopus
  9. N. J. McKenna and B. W. O'Malley, “SnapShot: nuclear receptors I,” Cell, vol. 142, no. 5, p. 822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. I. Dawson and Z. Xia, “The retinoid X receptors and their ligands,” Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, vol. 1821, no. 1, pp. 21–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Chambon, “A decade of molecular biology of retinoic acid receptors,” FASEB Journal, vol. 10, no. 9, pp. 940–954, 1996. View at Google Scholar · View at Scopus
  12. M. Leid, P. Kastner, R. Lyons et al., “Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently,” Cell, vol. 68, no. 2, pp. 377–395, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. P. L. Hallenbeck, M. S. Marks, R. E. Lippoldt, K. Ozato, and V. M. Nikodem, “Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXRβ) enhances DNA binding and TH-dependent transcriptional activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 12, pp. 5572–5576, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. V. C. Yu, C. Delsert, B. Andersen et al., “RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements,” Cell, vol. 67, no. 6, pp. 1251–1266, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. T. H. Bugge, J. Pohl, O. Lonnoy, and H. G. Stunnenberg, “RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors,” EMBO Journal, vol. 11, no. 4, pp. 1409–1418, 1992. View at Google Scholar · View at Scopus
  16. S. A. Kliewer, K. Umesono, D. J. Mangelsdorf, and R. M. Evans, “Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling,” Nature, vol. 355, no. 6359, pp. 446–449, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. K. L. Gearing, M. Gottlicher, M. Teboul, E. Widmark, and J.-A. Gustafsson, “Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 4, pp. 1440–1444, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Thaller and G. Eichele, “Identification and spatial distribution of retinoids in the developing chick limb bud,” Nature, vol. 327, no. 6123, pp. 625–628, 1987. View at Google Scholar · View at Scopus
  19. S. Keidel, M. Szardenings, and W. H. Mueller, “In vivo biological activity of retinoids partially correlates to their affinity to recombinant retinoic-acid receptor α and recombinant-cellular retinoic-acid-binding protein I,” European Journal of Biochemistry, vol. 212, no. 1, pp. 13–26, 1993. View at Google Scholar · View at Scopus
  20. D. J. Mangelsdorf, U. Borgmeyer, R. A. Heyman et al., “Characterization of three RXR genes that mediate the action of 9-cis retinoic acid,” Genes and Development, vol. 6, no. 3, pp. 329–344, 1992. View at Google Scholar · View at Scopus
  21. M. A. Kane, “Analysis, occurrence, and function of 9-cis-retinoic acid,” Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, vol. 1821, no. 1, pp. 10–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Boehm, L. Zhang, L. Zhi et al., “Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells,” Journal of Medicinal Chemistry, vol. 38, no. 16, pp. 3146–3155, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Boehm, L. Zhang, B. A. Badea et al., “Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids,” Journal of Medicinal Chemistry, vol. 37, no. 18, pp. 2930–2941, 1994. View at Google Scholar · View at Scopus
  24. E. Pérez, W. Bourguet, H. Gronemeyer, and A. R. De Lera, “Modulation of RXR function through ligand design,” Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, vol. 1821, no. 1, pp. 57–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Lotan, “Retinoids and apoptosis: implications for cancer chemoprevention and therapy,” Journal of the National Cancer Institute, vol. 87, no. 22, pp. 1655–1657, 1995. View at Google Scholar · View at Scopus
  26. N. Clarke, P. Germain, L. Altucci, and H. Gronemeyer, “Retinoids: potential in cancer prevention and therapy,” Expert Reviews in Molecular Medicine, vol. 6, no. 25, pp. 1–23, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Shankaranarayanan, A. Rossin, H. Khanwalkar et al., “Growth factor-antagonized rexinoid apoptosis involves permissive PPAR gamma/RXR heterodimers to activate the intrinsic death pathway by NO,” Cancer Cell, vol. 16, no. 3, pp. 220–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. P. Mahamuni, R. D. Khose, F. Menaa, and S. L. Badole, “Therapeutic approaches to drug targets in hyperlipidemia,” BioMedicine, vol. 2, no. 4, pp. 137–146, 2012. View at Google Scholar
  29. C.-H. Wang, W.-D. Lin, D.-T. Bau et al., “Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway,” BioMedicine, vol. 3, no. 2, pp. 82–87, 2013. View at Google Scholar
  30. T. Yamamoto, W.-C. Hung, T. Takano, and A. Nishiyama, “Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus,” BioMedicine, vol. 3, no. 1, pp. 2–18, 2013. View at Google Scholar
  31. Y.-M. Chang, B. K. Velmurugan, W. W. Kuo et al., “Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells,” BioMedicine, vol. 3, no. 4, pp. 148–152, 2013. View at Google Scholar
  32. Y. M. Leung, K. L. Wong, S. W. Chen et al., “Down-regulation of voltage-gated Ca2+ channels in Ca2+ store-depleted rat insulinoma RINm5F cells,” BioMedicine, vol. 3, no. 3, pp. 130–139, 2013. View at Google Scholar
  33. I. C. Chou, W.-D. Lin, and C.-H. Wang, “Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children,” BioMedicine, vol. 3, no. 2, pp. 88–91, 2013. View at Google Scholar
  34. H.-J. Huang, K.-J. Lee, H. W. Yu, H.-Y. Chen, F.-J. Tsai, and C. Y.-C. Chen, “A novel strategy for designing the selective PPAR agonist by the “Sum of activity” model,” Journal of Biomolecular Structure & Dynamics, vol. 28, no. 2, pp. 187–200, 2010. View at Google Scholar · View at Scopus
  35. P.-C. Chang, J.-D. Wang, M.-M. Lee et al., “Lose weight with traditional Chinese medicine? Potential suppression of fat mass and obesity-associated protein,” Journal of Biomolecular Structure & Dynamics, vol. 29, no. 3, pp. 471–483, 2011. View at Google Scholar · View at Scopus
  36. K. C. Chen, S. S. Chang, H. J. Huang et al., “Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine,” Journal of Biomolecular Structure & Dynamics, vol. 30, no. 6, pp. 662–683, 2012. View at Google Scholar
  37. K.-C. Chen and C. Yu-Chian Chen, “Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach,” Soft Matter, vol. 7, no. 8, pp. 4001–4008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. K.-C. Chen, K.-W. Chang, H.-Y. Chen, and C. Y.-C. Chen, “Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once?” Molecular BioSystems, vol. 7, no. 9, pp. 2711–2719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. T.-T. Chang, K.-C. Chen, K.-W. Chang et al., “In silico pharmacology suggests ginger extracts may reduce stroke risks,” Molecular BioSystems, vol. 7, no. 9, pp. 2702–2710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Ieongtou, S. S. Chang, D. Wu et al., “Molecular level activation insights from a NR2A/NR2B agonist,” Journal of Biomolecular Structure & Dynamics, 2013. View at Google Scholar
  41. C.-Y. Chen and C. Y.-C. Chen, “Insights into designing the dual-targeted HER2/HSP90 inhibitors,” Journal of Molecular Graphics and Modelling, vol. 29, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H.-J. Huang, K.-J. Lee, H. W. Yu et al., “Structure-based and ligand-based drug design for HER 2 receptor,” Journal of Biomolecular Structure & Dynamics, vol. 28, no. 1, pp. 23–37, 2010. View at Google Scholar · View at Scopus
  43. S.-C. Yang, S.-S. Chang, H.-Y. Chen, and C. Y.-C. Chen, “Identification of potent EGFR inhibitors from TCM Database@Taiwan,” PLoS Computational Biology, vol. 7, no. 10, Article ID e1002189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. A. Tsou, K. C. Chen, H. C. Lin, S. S. Chang, and C. Y. C. Chen, “Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study,” PLoS ONE, vol. 7, no. 11, Article ID e50087, 2012. View at Google Scholar
  45. Y. A. Tsou, K. C. Chen, S. S. Chang, Y. R. Wen, and C. Y. Chen, “A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors,” Journal of Biomolecular Structure & Dynamics, vol. 31, no. 12, pp. 1358–1369, 2013. View at Google Scholar
  46. C.-Y. Chen, Y.-H. Chang, D.-T. Bau et al., “Ligand-based dual target drug design for H1N1: swine flu—a preliminary first study,” Journal of Biomolecular Structure & Dynamics, vol. 27, no. 2, pp. 171–178, 2009. View at Google Scholar · View at Scopus
  47. C.-H. Lin, T.-T. Chang, M.-F. Sun et al., “Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database,” Journal of Biomolecular Structure & Dynamics, vol. 28, no. 4, pp. 471–482, 2011. View at Google Scholar · View at Scopus
  48. T.-T. Chang, M.-F. Sun, H.-Y. Chen et al., “Screening from the world's largest TCM database against H1N1 virus,” Journal of Biomolecular Structure & Dynamics, vol. 28, no. 5, pp. 773–786, 2011. View at Google Scholar · View at Scopus
  49. S.-S. Chang, H.-J. Huang, and C. Y.-C. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. H. J. Huang, Y. R. Jian, and C. Y. Chen, “Traditional Chinese medicine application in HIV: an in silico study,” Journal of Biomolecular Structure & Dynamics, vol. 32, no. 1, pp. 1–12, 2014. View at Google Scholar
  51. K. C. Chen, S. S. Chang, F. J. Tsai, and C. Y. Chen, “Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?” Journal of Biomolecular Structure & Dynamics, vol. 31, no. 11, pp. 1219–1235, 2013. View at Google Scholar
  52. K.-C. Chen, M.-F. Sun, S.-C. Yang et al., “Investigation into potent inflammation inhibitors from traditional chinese medicine,” Chemical Biology and Drug Design, vol. 78, no. 4, pp. 679–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. W. I. Tou, S. S. Chang, C. C. Lee, and C. Y. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, p. 844, 2013. View at Google Scholar
  54. K. C. Chen, Y. R. Jian, M. F. Sun et al., “Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine,” Journal of Biomolecular Structure & Dynamics, vol. 31, no. 11, pp. 1207–1218, 2013. View at Google Scholar
  55. W. I. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, 2013. View at Google Scholar
  56. C. Y. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Google Scholar
  57. V. Chandra, P. Huang, Y. Hamuro et al., “Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA,” Nature, vol. 456, no. 7220, pp. 350–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. B. R. Brooks, R. E. Bruccoleri, B. D. Olafson et al., “CHARMM: a program for macromolecular energy minimization and dynamics calculations,” Journal of Computational Chemistry, vol. 4, pp. 187–217, 1983. View at Google Scholar
  59. C. Y.-C. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,” Advanced Drug Delivery Reviews, vol. 46, no. 1–3, pp. 3–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically disordered amino acids,” Biochimica et Biophysica Acta. Proteins and Proteomics, vol. 1804, no. 4, pp. 996–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. C. M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, “LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites,” Journal of Molecular Graphics and Modelling, vol. 21, no. 4, pp. 289–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. B. Hess, C. Kutzner, D. Van Der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Zoete, M. A. Cuendet, A. Grosdidier, and O. Michielin, “SwissParam: a fast force field generation tool for small organic molecules,” Journal of Computational Chemistry, vol. 32, no. 11, pp. 2359–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Fletcher, Optimization, Academic Press, London, UK, 1969.